{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T05:15:37Z","timestamp":1739078137464,"version":"3.37.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","clinical-lung-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lung Cancer"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.cllc.2024.11.011","type":"journal-article","created":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T02:48:59Z","timestamp":1732330139000},"page":"e118-e125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of Lung Biomarker Testing on Out-Of-Pocket Costs for Metastatic Non\u2013Small-Cell Lung Cancer"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6420-9274","authenticated-orcid":false,"given":"Laila A.","family":"Gharzai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Bell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Divya M.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth C.","family":"Carlos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.cllc.2024.11.011_bib0001","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1001\/jama.2019.3241","article-title":"Association of patient characteristics and tumor genomics with clinical outcomes among patients with non-small cell lung cancer using a clinicogenomic database","volume":"321","author":"Singal","year":"2019","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.cllc.2024.11.011_bib0002","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1200\/JOP.2010.000166","article-title":"ASCO provisional clinical opinion: epidermal growth factor receptor mutation testing in practice","volume":"7","author":"Beasley","year":"2011","journal-title":"J Oncol Pract"},{"issue":"4","key":"10.1016\/j.cllc.2024.11.011_bib0003","doi-asserted-by":"crossref","first-page":"340","DOI":"10.6004\/jnccn.2023.0020","article-title":"NCCN guidelines(R) insights: non-small cell lung cancer, version 2.2023","volume":"21","author":"Ettinger","year":"2023","journal-title":"J Natl Compr Canc Netw"},{"issue":"3","key":"10.1016\/j.cllc.2024.11.011_bib0004","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1377\/hlthaff.2016.1627","article-title":"National health expenditure projections, 2016-25: price increases, aging push sector to 20 percent of economy","volume":"36","author":"Keehan","year":"2017","journal-title":"Health Aff (Millwood)"},{"issue":"6","key":"10.1016\/j.cllc.2024.11.011_bib0005","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nrclinonc.2017.31","article-title":"The high price of anticancer drugs: origins, implications, barriers, solutions","volume":"14","author":"Prasad","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"10.1016\/j.cllc.2024.11.011_bib0006","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/13696998.2022.2154479","article-title":"Costs of biomarker testing among patients with metastatic lung or thyroid cancer in the USA: a real-world commercial claims database study","volume":"26","author":"Hess","year":"2023","journal-title":"J Med Econ"},{"issue":"9","key":"10.1016\/j.cllc.2024.11.011_bib0007","doi-asserted-by":"crossref","first-page":"934-944 e1","DOI":"10.6004\/jnccn.2023.7039","article-title":"Biomarker testing, treatment, and outcomes in patients with advanced\/metastatic non-small cell lung cancer using a real-world database","volume":"21","author":"Bhandari","year":"2023","journal-title":"J Natl Compr Canc Netw."},{"issue":"6","key":"10.1016\/j.cllc.2024.11.011_bib0008","article-title":"Biomarker testing for patients with advanced\/metastatic nonsquamous NSCLC in the United States of America, 2015 to 2021","volume":"3","author":"Hess","year":"2022","journal-title":"JTO Clin Res Rep"},{"issue":"11","key":"10.1016\/j.cllc.2024.11.011_bib0009","doi-asserted-by":"crossref","first-page":"e1774","DOI":"10.1200\/OP.20.01023","article-title":"Association between Medicare's national coverage determination and utilization of next-generation sequencing","volume":"17","author":"Sheinson","year":"2021","journal-title":"JCO Oncol Pract."},{"key":"10.1016\/j.cllc.2024.11.011_bib0010","article-title":"Disparities in biomarker testing and clinical trial enrollment among patients with lung, breast, or colorectal cancers in the United States","volume":"6","author":"Bruno","year":"2022","journal-title":"JCO Precis Oncol."},{"issue":"3","key":"10.1016\/j.cllc.2024.11.011_bib0011","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3322\/caac.21714","article-title":"An overview of real-world data sources for oncology and considerations for research","volume":"72","author":"Penberthy","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.cllc.2024.11.011_bib0012","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.lungcan.2022.03.004","article-title":"Biomarker testing and tissue journey among patients with metastatic non-small cell lung cancer receiving first-line therapy in the US oncology network","volume":"166","author":"Robert","year":"2022","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.cllc.2024.11.011_bib0013","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.44923","article-title":"Trends in prices of drugs used to treat metastatic non-small cell lung cancer in the US from 2015 to 2020","volume":"5","author":"Desai","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"3","key":"10.1016\/j.cllc.2024.11.011_bib0014","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1200\/OP.23.00153","article-title":"Importance of patient health insurance coverage and out-of-pocket costs for genomic testing in oncologists\u2019 Treatment decisions","volume":"20","author":"Yabroff","year":"2024","journal-title":"JCO Oncol Pract."}],"container-title":["Clinical Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730424002559?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730424002559?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T12:34:28Z","timestamp":1739018068000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525730424002559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1525730424002559"],"URL":"https:\/\/doi.org\/10.1016\/j.cllc.2024.11.011","relation":{},"ISSN":["1525-7304"],"issn-type":[{"type":"print","value":"1525-7304"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Lung Biomarker Testing on Out-Of-Pocket Costs for Metastatic Non\u2013Small-Cell Lung Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cllc.2024.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}